MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study

MLA

Xiaojun Cai, et al. “MET Amplification Correlates with Poor Prognosis and Immunotherapy Response as a Subtype of Melanoma: A Multicenter Retrospective Study.” BMC Cancer, vol. 24, no. 1, Nov. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12885-024-13163-z.

APA

Xiaojun Cai, Jing Lin, Caili Li, Ting Xu, Chuanben Chen, Bin Lan, Xuefeng Wang, Shengjie Bai, Yufang Huang, Huishan Zhang, Lu Si, & Yu Chen. (2024). MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study. BMC Cancer, 24(1), 1–10. https://doi.org/10.1186/s12885-024-13163-z

Chicago

Xiaojun Cai, Jing Lin, Caili Li, Ting Xu, Chuanben Chen, Bin Lan, Xuefeng Wang, et al. 2024. “MET Amplification Correlates with Poor Prognosis and Immunotherapy Response as a Subtype of Melanoma: A Multicenter Retrospective Study.” BMC Cancer 24 (1): 1–10. doi:10.1186/s12885-024-13163-z.